WebMay 10, 2024 · Hikma Specialty USA Inc. 10 May 2024. KLOXXADO- naloxone hydrochloride spray Hikma Specialty USA Inc. 1 INDICATIONS AND USAGE . KLOXXADO is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients. ... WebHikma Pharmaceuticals USA Inc. 200 Connell Drive, 4th Floor Berkeley Heights, NJ 07922. Tel: 908-673-1030. Hikma 503B. Hikma Compounding, 503B 36 Stults Road Dayton, NJ 08810 US. Tel: 732-380-4440. Injectables Manufacturing Facility. Mailing Address; Hikma Pharmaceuticals USA Inc. 2 Esterbrook Lane
Hikma announces US FDA approval of KLOXXADOTM (naloxone hydrochloride …
WebOct 18, 2024 · Hikma Pharmaceuticals announced, on April 30, 2024, the US Food and Drug Administration (FDA) approval of Kloxxado ® (naloxone HCl) Nasal Spray 8 mg, a new opioid overdose reversal medication. This announcement came as drug overdose deaths continued to increase during the COVID-19 pandemic. 1 WebWe are deeply committed to providing our customers with a broad range of essential medicines that physicians and pharmacists need to treat their patients. Because for us, … henley invesco
Chris Bonny - Vice President of Marketing, Hikma Pharmaceuticals USA …
WebWho is Hikma Specialty USA Headquarters 1900 Arlingate Ln, Columbus, Ohio, 43228, United States Phone Number (800) 631-2174 Website www.hikma-specialty.com Revenue $9.3M Industry Drug Stores & Pharmacies Retail Hikma Specialty USA's Social Media Is this data correct? View contact profiles from Hikma Specialty USA Popular Searches WebApr 30, 2024 · LONDON, April 30, 2024 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the approval of KLOXXADO TM (naloxone hydrochloride) nasal spray... WebJan 4, 2024 · Hikma is a top three supplier of generic injectable medicines by volume in the US with a portfolio of over 130 products. [2] “As an experienced provider of addiction therapy treatments we are pleased to be able to leverage our capabilities to deliver another important new tool in this fight,” said Riad Mishlawi, President of Hikma Injectables. henley international hi low table